• PQS: Updated antibiotic review data published

    The NHS Business Services Authority (NHSBSA) has updated their antibiotic review spreadsheet for the Pharmacy Quality Scheme (PQS) 2022/23. As part of the Prevention domain, contractors are required to carry out a TARGET leaflet review (further details of the requirements can be found on the PSNC PQS hub page under the ‘Domain 4 – Prevention’

    Read more
  • Last few days to submit valproate audit data

    7,410 contractors have submitted their valproate audit data; have you submitted your data yet? By 31st March 2023, all community pharmacy contractors must have completed the 2022/23 national clinical audit on valproate over a six-week consecutive period and have submitted their data via the Valproate audit 2022/23 tab on MYS. This is a mandatory contractual

    Read more
  • Medicine Supply Notification: Acetazolamide (Diamox® SR) 250mg modified-release capsules

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Acetazolamide (Diamox® SR) 250mg modified-release capsules. MSN/2023/033 Tier 2 – medium impact Date of issue 27th March 2023 Acetazolamide (Diamox® SR) 250mg modified-release capsules are out of stock until end of July 2023. Acetazolamide immediate release 250mg tablets remain available and

    Read more
  • PQS: Updated data on NHS DWMP referrals

    The NHS Business Services Authority (NHSBSA) has updated its spreadsheet showing which community pharmacy contractors have made a referral to the NHS Digital Weight Management Programme (DWMP) as part of the Pharmacy Quality Scheme (PQS) 2022/23. To gain the maximum number of points and to meet the Referral stage of the Healthy living support domain,

    Read more
  • Medicine Supply Notification: Estradiol valerate/medroxyprogesterone acetate (Indivina® ) 1mg/2.5mg tablets

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Estradiol valerate/medroxyprogesterone acetate (Indivina®) 1mg/2.5mg tablets. MSN/2023/034 Tier 2 – medium impact Date of issue 27th March 2023 Estradiol valerate/medroxyprogesterone acetate (Indivina®) 1mg/2.5mg tablets is out of stock until w/c 26th June 2023. Alternative continuous combined hormone replacement therapies (HRT) containing

    Read more
  • Pharmacy IT workstreams update published

    PSNC has published a roundup of the quarterly meeting of the Community Pharmacy IT Group (CP ITG) that was held during March 2023 and pharmacy IT developments. This IT bulletin includes updates on: Considerations regarding current pharmacy IT prioritisation Updates on the National Care Records Service (NCRS) portal which will replace the Summary Care Record

    Read more
  • Medicine Supply Notification: Primidone (Aspire Pharma) 50mg tablets

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Primidone (Aspire Pharma) 50mg tablets. MSN/2023/032 Tier 2 – medium impact Date of issue 27th March 2023 Primidone (Aspire Pharma) 50mg tablets are out of stock until w/c 24th April 2023 Teva brand of primidone 50mg tablets remain available and will

    Read more
  • 2023 PSNC Election Results

    Voting has closed in ballots for three Regional Representatives* and non-CCA Multiple Representatives on PSNC (soon to be known as Community Pharmacy England). Completed voting forms received by the close of voting (12 noon on Friday 24th March 2023) have been counted and validated. The results can now be declared as follows.   East of

    Read more
  • April 2023 Category M prices announced

    The Drug Tariff Category M pricelist for April 2023 has been published on the NHS Business Services Authority (NHSBSA) website. The April Category M prices reflect a moderate increase in reimbursement levels which is the net effect of 3 elements; A significant adjustment in Category M prices in recognition of the price rises that have

    Read more
  • HRT PPC: Guidance and FAQs now available

    Ahead of the Government’s introduction of the new Prescription Prepayment Certificate (PPC) for hormone replacement therapy (HRT) products on 1 April, PSNC has published guidance and FAQs to help pharmacy teams to implement this new policy. Background and Latest Position From 1 April 2023, patients who are not already exempt from NHS prescription charges will be

    Read more